Announced details
Procurement, manufacturing, storage, transportation and delivery of pharmaceuticals, medical equipment and supplies, OTC products and other healthcare products, as well as last-mile delivery for medical care, nursing care and home care
大木ヘルスケアホールディングス plans to participate in 株式会社コラボクリエイト's business through an investment and the secondment of personnel. SUZUKEN CO.,LTD. will hold 100% of 株式会社コラボクリエイト at establishment, with its holding scheduled to be 55% after the capital increase. No investment ratio or investment amount for 大木ヘルスケアホールディングス is stated.
株式会社コラボクリエイト: 14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo; Representative Director and President: Soejima Hidetsugu (副島秀継); scheduled for establishment on 1 April 2026; capital of ¥50 million (scheduled to increase to ¥100 million after the capital increase); contract logistics services for pharmaceutical manufacturers and comprehensive proposal and contract logistics services for healthcare products; shareholders: SUZUKEN CO.,LTD. 100% (scheduled to be 55% after the capital increase); 15 employees at establishment (scheduled to be approximately 30 after the capital increase). SUZUKEN CO.,LTD.: 8 Higashikatabata-cho, Higashi-ku, Nagoya, Aichi; Representative Director and President: Asano Shigeru (浅野茂); sales of prescription pharmaceuticals, reagents, medical equipment, medical supplies and food products, as well as development and manufacture of medical equipment; founded on 13 November 1932.
14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Healthcare logistics business addressing social issues |
| Counterparty | 株式会社コラボクリエイト, SUZUKEN CO.,LTD. |
| Counterparty overview | 株式会社コラボクリエイト: 14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo; Representative Director and President: Soejima Hidetsugu (副島秀継); scheduled for establishment on 1 April 2026; capital of ¥50 million (scheduled to increase to ¥100 million after the capital increase); contract logistics services for pharmaceutical manufacturers and comprehensive proposal and contract logistics services for healthcare products; shareholders: SUZUKEN CO.,LTD. 100% (scheduled to be 55% after the capital increase); 15 employees at establishment (scheduled to be approximately 30 after the capital increase). SUZUKEN CO.,LTD.: 8 Higashikatabata-cho, Higashi-ku, Nagoya, Aichi; Representative Director and President: Asano Shigeru (浅野茂); sales of prescription pharmaceuticals, reagents, medical equipment, medical supplies and food products, as well as development and manufacture of medical equipment; founded on 13 November 1932. |
| Relationship with the Company | 大木ヘルスケアホールディングス plans to participate in 株式会社コラボクリエイト's business through an investment and the secondment of personnel. SUZUKEN CO.,LTD. will hold 100% of 株式会社コラボクリエイト at establishment, with its holding scheduled to be 55% after the capital increase. No investment ratio or investment amount for 大木ヘルスケアホールディングス is stated. |
| Launch date | 1 April 2026 (scheduled establishment date) |
| Applicable area | Procurement, manufacturing, storage, transportation and delivery of pharmaceuticals, medical equipment and supplies, OTC products and other healthcare products, as well as last-mile delivery for medical care, nursing care and home care |
| Location | 14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo |
| Location scale | Employees: 15 at establishment, scheduled to be approximately 30 after the capital increase |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Labor shortages, regional disparities in access to healthcare, constrained transportation and delivery capacity, and the need to maintain stable supplies during disasters are becoming more serious issues in the medical and healthcare industries. Because there are limits to what a single company can achieve in addressing these issues, the participating companies aim to resolve healthcare logistics challenges by combining their assets, capabilities and expertise.